MCL-1 is a clinically targetable vulnerability in breast cancer

por Winder, Matthew L, Campbell, Kirsteen J
Publicado 2022

Targeting BCL-2 regulated apoptosis in cancer

por Campbell, Kirsteen J., Tait, Stephen W. G.
Publicado 2018

Differential regulation of NF-κB activation and function by topoisomerase II inhibitors

por Campbell, Kirsteen J, O'Shea, John M, Perkins, Neil D
Publicado 2006

The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context

por Khan, Adiba S., Campbell, Kirsteen J., Cameron, Ewan R., Blyth, Karen
Publicado 2023

The p53-inhibitor Pifithrin-α inhibits Firefly Luciferase activity in vivo and in vitro

por Rocha, Sonia, Campbell, Kirsteen J, Roche, Kevin C, Perkins, Neil D
Publicado 2003

Mnt modulates Myc-driven lymphomagenesis

por Campbell, Kirsteen J, Vandenberg, Cassandra J, Anstee, Natasha S, Hurlin, Peter J, Cory, Suzanne
Publicado 2017

Cezanne regulates E2F1-dependent HIF2α expression

por Moniz, Sonia, Bandarra, Daniel, Biddlestone, John, Campbell, Kirsteen J., Komander, David, Bremm, Anja, Rocha, Sonia
Publicado 2015

Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice

por Anstee, Natasha S, Vandenberg, Cassandra J, Campbell, Kirsteen J, Hughes, Peter D, O'Reilly, Lorraine A, Cory, Suzanne
Publicado 2017

Apoptotic stress-induced FGF signalling promotes non-cell autonomous resistance to cell death

por Bock, Florian J., Sedov, Egor, Koren, Elle, Koessinger, Anna L., Cloix, Catherine, Zerbst, Désirée, Athineos, Dimitris, Anand, Jayanthi, Campbell, Kirsteen J., Blyth, Karen, Fuchs, Yaron, Tait, Stephen W. G.
Publicado 2021

MCL-1 is a prognostic indicator and drug target in breast cancer

por Campbell, Kirsteen J., Dhayade, Sandeep, Ferrari, Nicola, Sims, Andrew H., Johnson, Emma, Mason, Susan M., Dickson, Ashley, Ryan, Kevin M., Kalna, Gabriela, Edwards, Joanne, Tait, Stephen W. G., Blyth, Karen
Publicado 2018

Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function

por Campbell, Kirsteen J., Mason, Susan M., Winder, Matthew L., Willemsen, Rosalie B. E., Cloix, Catherine, Lawson, Hannah, Rooney, Nicholas, Dhayade, Sandeep, Sims, Andrew H., Blyth, Karen, Tait, Stephen W. G.
Publicado 2021

Mitochondrial dynamics regulate genome stability via control of caspase-dependent DNA damage

por Cao, Kai, Riley, Joel S., Heilig, Rosalie, Montes-Gómez, Alfredo E., Vringer, Esmee, Berthenet, Kevin, Cloix, Catherine, Elmasry, Yassmin, Spiller, David G., Ichim, Gabriel, Campbell, Kirsteen J., Gilmore, Andrew P., Tait, Stephen W.G.
Publicado 2022

Brf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas

por Liko, Dritan, Mitchell, Louise, Campbell, Kirsteen J., Ridgway, Rachel A., Jones, Carolyn, Dudek, Kate, King, Ayala, Bryson, Sheila, Stevenson, David, Blyth, Karen, Strathdee, Douglas, Morton, Jennifer P., Bird, Thomas G., Knight, John R. P., Willis, Anne E., Sansom, Owen J.
Publicado 2019

Condensin II mutation causes T-cell lymphoma through tissue-specific genome instability

por Woodward, Jessica, Taylor, Gillian C., Soares, Dinesh C., Boyle, Shelagh, Sie, Daoud, Read, David, Chathoth, Keerthi, Vukovic, Milica, Tarrats, Nuria, Jamieson, David, Campbell, Kirsteen J., Blyth, Karen, Acosta, Juan Carlos, Ylstra, Bauke, Arends, Mark J., Kranc, Kamil R., Jackson, Andrew P., Bickmore, Wendy A., Wood, Andrew J.
Publicado 2016

CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation

por Lawson, Hannah, van de Lagemaat, Louie N., Barile, Melania, Tavosanis, Andrea, Durko, Jozef, Villacreces, Arnaud, Bellani, Aarushi, Mapperley, Christopher, Georges, Elise, Martins-Costa, Catarina, Sepulveda, Catarina, Allen, Lewis, Campos, Joana, Campbell, Kirsteen J., O'Carroll, Dónal, Göttgens, Berthold, Cory, Suzanne, Rodrigues, Neil P., Guitart, Amelie V., Kranc, Kamil R.
Publicado 2021

BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration

por Loveridge, Carolyn J., Slater, Sarah, Campbell, Kirsteen J., Nam, Noor A., Knight, John, Ahmad, Imran, Hedley, Ann, Lilla, Sergio, Repiscak, Peter, Patel, Rachana, Salji, Mark, Fleming, Janis, Mitchell, Louise, Nixon, Colin, Strathdee, Douglas, Neilson, Matthew, Ntala, Chara, Bryson, Sheila, Zanivan, Sara, Edwards, Joanne, Robson, Craig N., Goodyear, Carl S., Blyth, Karen, Leung, Hing Y.
Publicado 2019

Correction: BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration

por Loveridge, Carolyn J., Slater, Sarah, Campbell, Kirsteen J., Nam, Noor A., Knight, John, Ahmad, Imran, Hedley, Ann, Lilla, Sergio, Repiscak, Peter, Patel, Rachana, Salji, Mark, Fleming, Janis, Mitchell, Louise, Nixon, Colin, Strathdee, Douglas, Neilson, Matthew, Ntala, Chara, Bryson, Sheila, Zanivan, Sara, Edwards, Joanne, Robson, Craig N., Goodyear, Carl S., Blyth, Karen, Leung, Hing Y.
Publicado 2019

Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics

por Koessinger, Anna L., Cloix, Catherine, Koessinger, Dominik, Heiland, Dieter Henrik, Bock, Florian J., Strathdee, Karen, Kinch, Kevin, Martínez-Escardó, Laura, Paul, Nikki R., Nixon, Colin, Malviya, Gaurav, Jackson, Mark R., Campbell, Kirsteen J., Stevenson, Katrina, Davis, Sandeep, Elmasry, Yassmin, Ahmed, Asma, O’Prey, Jim, Ichim, Gabriel, Schnell, Oliver, Stewart, William, Blyth, Karen, Ryan, Kevin M., Chalmers, Anthony J., Norman, Jim C., Tait, Stephen W. G.
Publicado 2022

Spatial regulation of the glycocalyx component podocalyxin is a switch for prometastatic function

por Román-Fernández, Alvaro, Mansour, Mohammed A., Kugeratski, Fernanda G., Anand, Jayanthi, Sandilands, Emma, Galbraith, Laura, Rakovic, Kai, Freckmann, Eva C., Cumming, Erin M., Park, Ji, Nikolatou, Konstantina, Lilla, Sergio, Shaw, Robin, Strachan, David, Mason, Susan, Patel, Rachana, McGarry, Lynn, Katoch, Archana, Campbell, Kirsteen J., Nixon, Colin, Miller, Crispin J., Leung, Hing Y., Le Quesne, John, Norman, James C., Zanivan, Sara, Blyth, Karen, Bryant, David M.
Publicado 2023